MENU
ATNM
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Actinium Pharmaceuticals (ATNM) Ownership - Who owns Actinium Pharmaceuticals?

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
100 Park Avenue
Phone
+1 646 677-3870
Employees
25
Web
https://www.actiniumpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
32.32M
P/E Ratio
N/A
Total Cash
42.13M
Projected Growth
N/A
Total Debt
1.52M
Revenue
90K
Risk (Beta)
-0.04
Dividend Yield
N/A
Total Cash/Share
1.34
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
ATNM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
100 Park Avenue
Phone
+1 646 677-3870
Employees
25
Web
https://www.actiniumpharma.com